The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial
Authors
John A. Smith (ORCID: https://orcid.org/0000-0001-8837-4928)
A. John Simpson (ORCID: https://orcid.org/0000-0003-4731-7294)
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
3.04
Funders
Health Technology Assessment Programme
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial
John A. Smith, A. John Simpson, Ganesh Raghu, Chris Ward et al.
Citations
2 citations
Journal
BMJ Open
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Field-Weighted Citation Impact (FWCI)
3.04
article
The effectiveness and risks of Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole (TIPAL): study protocol for a randomised placebo-controlled multicentre clinical trial
John A. Smith, A. John Simpson, Ganesh Raghu, Chris Ward, Nazia Chaudhuri, David Thickett, Helen Parfrey, Megan Jones, Anthony Cahn, Lisa Spencer, Toby M. Maher, Stephen E. Jones, Shajahan Wahed, Allan Clark, Luke Vale, Andrew M. Wilson, Ian Forrest, Matthew Hammond
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
University of East Anglia (GB), University of Southern California (US), University of Ulster (GB), University of Liverpool (GB), GlaxoSmithKline (United Kingdom) (GB), Aintree University Hospitals NHS Foundation Trust (GB), Royal Victoria Infirmary (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), University of Washington Medical Center (US), University of Manchester (GB), Papworth Hospital NHS Foundation Trust (GB), Newcastle upon Tyne Hospital (GB), University of Birmingham (GB), Newcastle University (GB)
Funders
Health Technology Assessment Programme
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 11%
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis